AKLRD

AKL Research and Development

AKLRD develops novel solutions for inflammatory diseases with a high unmet need

Over 2%

The burden to society of osteoarthritis in developed counties is more than 2% annual GDP

NEWS

Personalised Medicine & Disease Modification in OA

Read More

NEWS

How close are disease‐modifying drugs for OA?

Read More

NEWS

Phase II osteoarthritis clinical trial underway

Read More